Travere Therapeutics (TVTX) traded down -4.48 % during a 24 hours period ending at 05:16 PM Central Europe on Monday 26th. One Travere Therapeutics stock can currently be bought for about USD 49.65 on popular exchanges. Current supply of Travere Therapeutics stocks is 94.2 mn. Travere Therapeutics has a current market capitalization of USD 4.7 bn and approximately USD 115.9 mn worth of Travere Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Travere Therapeutics has traded -17.39 % down. Simple moving average of last 200 days is at USD 46.16. The highest price of past 52 weeks was recorded at USD 68.73 on 09/11/2026. 52 weeks low was at USD 22.59 on 01/13/2026.
Here is how related stocks have performed in the past 24 hours:
Terawulf (WULF) traded flat 0 % and now trades at USD 12.18. Current market capitalisation for Terawulf is USD 5.7 bn.
Sensient (SXT) traded up 1.31 % and now trades at USD 131.68. Current market capitalisation for Sensient is USD 5.6 bn. Sensient has a current price to earnings ratio of 35.59.
Landstar System (LSTR) traded down -2.13 % and now trades at USD 166.36. Current market capitalisation for Landstar System is USD 5.6 bn. Current price/earnings ratio for Landstar System is 43.09.
Bgc (BGC) traded down -0.84 % and now trades at USD 11.76. Current market capitalisation for Bgc is USD 5.6 bn. Bgc has a current price to earnings ratio of 29.57.
Jbt Marel (JBTM) traded down -1 % and now trades at USD 108.77. Current market capitalisation for Jbt Marel is USD 5.6 bn. Jbt Marel has a current price to earnings ratio of 29.39.
About Travere Therapeutics
Travere Therapeutics, Inc. is a biopharmaceutical company that specializes in identifying, developing, and delivering therapies to individuals living with rare diseases. The company has its main operations in San Diego, United States, and provides global services to customers.
